Research Topic

Sixty-four drugs have been filed with the FDA and have anticipated approval dates in 2020, according to OptumRx's Drug Pipeline Insights Report.

Australian Gold has eliminated oxybenzone and octinoxate from its products as part of a reformulation and relaunch.

According to a new study from Button, there was a 68% increase in mobile spending per shopper during the 2019 holiday season compared to the same period in 2018.

Jelly Belly’s BeanBoozled Fiery Five channels the flavors of sriracha sauce, as well as jalapeño, cayenne, habanero and Carolina reaper peppers.

In addition to promoting several staffers, the Council for Responsible Nutrition has added Luke Huber as vice president of scientific and regulatory affairs and Amanda Darlington as director of government relations. 

Drug pricing and reimbursement constraints will have the greatest negative impact on the pharmaceutical industry in 2020, according to a new report from data and analytics company GlobalData.

Intra-Cellular plans to launch Caplyta in the first quarter of this year.

H-E-B was rated the top U.S. grocery retailer, according to the annual Retailer Preference Index.